JPWO2020235587A1 - - Google Patents

Info

Publication number
JPWO2020235587A1
JPWO2020235587A1 JP2021520813A JP2021520813A JPWO2020235587A1 JP WO2020235587 A1 JPWO2020235587 A1 JP WO2020235587A1 JP 2021520813 A JP2021520813 A JP 2021520813A JP 2021520813 A JP2021520813 A JP 2021520813A JP WO2020235587 A1 JPWO2020235587 A1 JP WO2020235587A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021520813A
Other languages
Japanese (ja)
Other versions
JP7496555B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020235587A1 publication Critical patent/JPWO2020235587A1/ja
Application granted granted Critical
Publication of JP7496555B2 publication Critical patent/JP7496555B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/72—4,7-Endo-alkylene-iso-indoles
    • C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021520813A 2019-05-21 2020-05-20 タンドスピロン誘導体 Active JP7496555B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019095359 2019-05-21
JP2019095359 2019-05-21
PCT/JP2020/019911 WO2020235587A1 (fr) 2019-05-21 2020-05-20 Dérivé de tandospirone

Publications (2)

Publication Number Publication Date
JPWO2020235587A1 true JPWO2020235587A1 (fr) 2020-11-26
JP7496555B2 JP7496555B2 (ja) 2024-06-07

Family

ID=

Also Published As

Publication number Publication date
WO2020235587A1 (fr) 2020-11-26

Similar Documents

Publication Publication Date Title
BR112021017339A2 (fr)
BR112021018450A2 (fr)
BR112021017939A2 (fr)
BR112021017892A2 (fr)
AU2020104490A4 (fr)
BR112021017738A2 (fr)
BR112021017782A2 (fr)
BR112021018168A2 (fr)
BR112021017728A2 (fr)
BR112021017234A2 (fr)
BR112021017355A2 (fr)
BR112021017173A2 (fr)
BR112021018102A2 (fr)
BR112021017083A2 (fr)
BR112021018452A2 (fr)
BR112021018250A2 (fr)
BR112021018093A2 (fr)
BR112021018084A2 (fr)
BR112021017703A2 (fr)
BR112021018484A2 (fr)
BR112021017732A2 (fr)
BR112021017949A2 (fr)
BR112021017983A2 (fr)
BR112021016996A2 (fr)
BR112021017010A2 (fr)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210811

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230407

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240514

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240517